Position in AMGN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$1,177,976
+$210,390 QoQ
Shares Held
3,253
+18.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#1,592
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Grove Bank & Trust holds $25,083,993 across 15 Drug Manufacturers - General names. AMGN ranks #6 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,571 | $9,080,885 | |
| 2 | ABBV |
AbbVie Inc.
|
15,353 | $3,863,428 | |
| 3 | JNJ |
Johnson & Johnson
|
15,184 | $3,856,280 | |
| 4 | MRK |
Merck & Co., Inc.
|
15,556 | $1,998,945 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
22,434 | $1,292,646 | |
| 6 | AMGN |
Amgen Inc
This page
|
3,253 | $1,177,976 | |
| 7 | AZN |
Astrazeneca PLC
|
5,776 | $1,095,244 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
6,271 | $792,278 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,177,976 | 3,253 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $967,586 | 2,750 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $898,792 | 2,746 | Shares | Defined | 2026-01-08 | |
| 2025-09-30 | $770,123 | 2,729 | Shares | Defined | 2025-10-06 | |
| 2025-06-30 | $761,963 | 2,729 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $863,927 | 2,773 | Shares | Defined | 2025-04-17 | |
| 2024-12-31 | $716,760 | 2,750 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $856,111 | 2,657 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $797,372 | 2,552 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $761,124 | 2,677 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $1,367,806 | 4,749 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,661,743 | 6,183 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $1,238,871 | 5,580 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $1,103,347 | 4,564 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $1,047,933 | 3,990 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,077,862 | 4,782 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $1,015,534 | 4,174 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $981,063 | 4,057 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $765,122 | 3,401 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $677,502 | 3,186 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $788,531 | 3,235 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $789,225 | 3,172 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $727,466 | 3,164 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $770,358 | 3,031 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $728,099 | 3,087 | Shares | Sole | 2020-07-31 | |
| 2020-03-31 | $546,154 | 2,694 | Shares | Sole | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||